Arthrosis

0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
3 programs
AMIStem-PN/A1 trial
Quadra P antevertedN/A1 trial
SMS femoral stemN/A1 trial
Active Trials
NCT04997005Active Not RecruitingEst. Dec 2032
NCT05460715Active Not RecruitingEst. Jul 2032
NCT02748408RecruitingEst. Jul 2032

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
MedactaQuadra P anteverted
MedactaAMIStem-P
MedactaSMS femoral stem

Clinical Trials (3)

NCT05460715MedactaQuadra P anteverted

The Medacta Quadra-P Anteverted Study

Start: Jul 2021Est. completion: Jul 2032
N/AActive Not Recruiting
NCT04997005MedactaAMIStem-P

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Start: Apr 2019Est. completion: Dec 2032
N/AActive Not Recruiting
NCT02748408MedactaSMS femoral stem

The Medacta International SMS Post-Marketing Surveillance Study

Start: Jul 2015Est. completion: Jul 2032
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space